Published in J Urol on November 01, 1979
[The WHO/ISUP grading system for renal carcinoma]. Pathologe (2016) 0.80
Hypernephroma. Br Med J (Clin Res Ed) (1981) 0.75
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol (2001) 11.35
Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses. Virology (1974) 6.53
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA (1993) 5.77
Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med (1994) 4.34
The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol (1993) 3.66
Natural history of prostatism: risk factors for acute urinary retention. J Urol (1997) 3.59
Infectious C-type virus isolated from a baboon placenta. Nature (1974) 3.32
A distinct class of inducible murine type-C viruses that replicates in the rabbit SIRC cell line. Proc Natl Acad Sci U S A (1974) 3.00
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res (1997) 2.80
Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer. BJU Int (2003) 2.78
Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci U S A (1975) 2.71
Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA (1995) 2.70
Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer (1971) 2.56
Type C viruses of baboons: isolation from normal cell cultures. Cell (1974) 2.55
Nucleic acid homology of murine type-C viral genes. J Virol (1974) 2.51
Stenosis of the afferent antireflux valve in the Kock pouch continent urinary diversion: diagnosis and management. J Urol (1994) 2.24
Small renal parenchymal neoplasms: further observations on growth. Radiology (1995) 2.15
Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst (1995) 2.10
Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J Urol (1999) 2.08
Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst (1998) 2.07
The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2) J Urol (1990) 2.07
A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med (1993) 2.05
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol (1993) 1.85
S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens. Int J Cancer (1974) 1.84
Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol (1995) 1.82
Nucleic acid homology of murine xenotropic type C viruses. J Virol (1975) 1.82
Characterization of a type C virus released from the porcine cell line PK(15). Virology (1974) 1.81
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol (2000) 1.81
Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol (2001) 1.79
Mammalian cells in culture frequently release type C viruses. Science (1973) 1.79
Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol (1994) 1.75
Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol (1995) 1.75
Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol (1996) 1.73
Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst (1999) 1.70
Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology (1998) 1.68
Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res (1990) 1.67
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (1999) 1.67
Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res (1998) 1.65
Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol (1992) 1.65
Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol (1995) 1.63
Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol (1998) 1.59
Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology (1998) 1.57
Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol (1985) 1.55
Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol (1999) 1.53
Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol (1996) 1.53
Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res (1995) 1.52
Endogenous primate and feline type C viruses. Cold Spring Harb Symp Quant Biol (1975) 1.51
Diagnostic ultrasound in the evaluation of scrotal masses. J Urol (1977) 1.48
Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol (1999) 1.48
p53 protein and gene alterations in pathological stage C prostate carcinoma. J Urol (1997) 1.45
Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst (1997) 1.45
Natural history of benign prostatic hyperplasia. Urology (2001) 1.45
Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol (1995) 1.44
Infectious primate type C viruses: Three isolates belonging to a new subgroup from the brains of normal gibbons. Virology (1975) 1.42
Stereotaxic aspiration biopsy in the evaluation of mammographically detected clustered microcalcification. Cancer (1998) 1.42
Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology (1998) 1.41
A prospective randomized comparison of epidural infusion of fentanyl and intravenous administration of morphine by patient-controlled analgesia after radical retropubic prostatectomy. Mayo Clin Proc (1992) 1.40
Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumors. Urology (1994) 1.39
Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens. J Urol (1995) 1.38
Fine needle aspiration biopsy of proliferative breast disease. Mod Pathol (1995) 1.38
Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol (1996) 1.37
Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol (1998) 1.37
Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch. J Urol (1999) 1.36
p53 and treatment of bladder cancer. Nature (1997) 1.36
Longitudinal changes in peak urinary flow rates in a community based cohort. J Urol (2000) 1.34
Aspiration biopsy of prostate. Urology (1982) 1.32
Giant adrenal myelolipoma and testicular interstitial cell tumor in a man with congenital 21-hydroxylase deficiency. Am J Surg Pathol (1979) 1.31
Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder: updated experience in 34 patients. J Urol (1997) 1.30
Biologic and immunologic properties of porcine type C viruses. Virology (1975) 1.28
International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol (2001) 1.28
Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology (1997) 1.27
Natural history of prostatism: factors associated with discordance between frequency and bother of urinary symptoms. Urology (1993) 1.27
New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States. Arch Intern Med (1995) 1.27
Application of a human tumor colony-forming assay to new drug screening. Cancer Res (1985) 1.26
Endogenous baboon type C virus (M7): biochemical and immunologic characterization. Virology (1974) 1.25
Comparison of studer ileal neobladder and ileal conduit urinary diversion with respect to perioperative outcome and late complications. J Urol (1998) 1.21
Papillary (transitional) carcinoma in an ileal conduit. J Urol (1975) 1.19
Cell aggregates in the soft agar "human tumour stem-cell assay". Br J Cancer (1982) 1.19
Adrenal cortical carcinoma associated with venous tumour thrombus extension. Br J Urol (1997) 1.19
Influence of patient age on the serum PSA concentration. An important clinical observation. Urol Clin North Am (1993) 1.19
Quality of life survey of urinary diversion patients: comparison of ileal conduits versus continent Kock ileal reservoirs. J Urol (1987) 1.18
Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management. J Urol (1972) 1.18
Infectious type C viruses released by normal cat embryo cells. Virology (1973) 1.18
Decline of sexual function with age in Japanese men compared with American men--results of two community-based studies. Urology (1999) 1.17
Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res (1994) 1.16
Sexual function of men ages 40 to 79 years: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. J Am Geriatr Soc (1995) 1.16
Management of the patient with bladder cancer. Urethral recurrence. Urol Clin North Am (1994) 1.16
Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men? Urology (1995) 1.15
Management of adult sarcomas of the bladder and prostate. J Urol (1988) 1.15
Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization. J Urol (1997) 1.15
Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol (1999) 1.15
Superinduction of endogenous type C virus by 5-bromodeoxyuridine from transformed mouse clones. Science (1973) 1.14
Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol (1995) 1.13
Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc (1998) 1.13
Role of chromosome 9 in human bladder cancer. Cancer Res (1993) 1.13
The natural history of prostatism: the effects of non-response bias. Int J Epidemiol (1994) 1.12
Congenital cystic disease of the seminal vesicle. Radiology (1991) 1.12
A cell line (SCABER) derived from squamous cell carcinoma of the human urinary bladder. Int J Cancer (1976) 1.12
Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. J Urol (1996) 1.12